Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Sleep Wake Disorders 1Pain 1Hot Flashes 1Endometrial Neoplasms 1Carcinoma, Lobular 1Carcinoma, Intraductal, Noninfiltrating 1Breast Neoplasms 1Breast Carcinoma In Situ 1

Interventions

Early Intervention, Educational 7Methods 6Practice Guidelines as Topic 5Standard of Care 4Educational Status 4Counseling 4Radiotherapy 3Neoadjuvant Therapy 3Magnetic Resonance Spectroscopy 3Biopsy 3Behavior Therapy 3Therapeutics 2Tamoxifen 2Surveys and Questionnaires 2Radiotherapy, Conformal 2Radiation Dose Hypofractionation 2Psychiatric Rehabilitation 2Interviews as Topic 2Chemotherapy, Adjuvant 2Brachytherapy 2Zolpidem 1Yoga 1Venlafaxine Hydrochloride 1Telemedicine 1Specimen Handling 1Soybean Proteins 1Sentinel Lymph Node Biopsy 1Radiotherapy, Intensity-Modulated 1Radiosurgery 1Radiofrequency Ablation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Breast Carcinoma In Situ × Zolpidem × Clear all
NCT00084669 2010-04-28

Venlafaxine With or Without Zolpidem in Treating Hot Flashes and Associated Sleep Disorders in Women With Breast Cancer OR at High Risk for Developing Breast Cancer

Massachusetts General Hospital

Phase NA Completed
119 enrolled
Breast

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating, Sleep Wake Disorders, Carcinoma, Lobular, Hot Flashes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡